Innovative Pharmaceutical Biotech Limited has announced the issuance of new shares under a general mandate. The company, which is listed on the Main Board of the Stock Exchange, is set to issue up to 344,638,604 shares, representing about 20% of its current share capital. This decision follows the approval of the general mandate at the company's annual general meeting. The subscription involves 137,600,000 shares priced at HK$0.176 per share. Investors are advised to exercise caution when dealing with the company's securities.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。